<DOC>
	<DOC>NCT01526122</DOC>
	<brief_summary>The purpose of this study is to compare characteristics and safety after oral administration of G0041(75/100mg) 2 tablets with those of Clopidogrel 75mg 2 tablets &amp; Aspirin 100mg 2 capsules coadministration in healthy male volunteers.</brief_summary>
	<brief_title>Pharmacokinetics &amp; Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>healthy male volunteers between the ages of 20 to 50 years old weight more than 55kg and within the range of ±20% of IBW having neither congenital/chronic diseases nor pathological symptoms/findings as results of medical examination doctor determines to be suitable as subjects within 3 weeks ago before administration Hypersensitivitiy(or history of hypersensitivity) to aspirin and clopidogrel Active Liver Diseases or exceed 1.5 times the normal range of AST, ALT, total bilirubin Exceed the normal range of PT, aPTT, BT &amp; platelet counts under 150,000/㎣ or exceed 350,000/㎣ Creatinine clearance &lt; 80 mL/min Gastrointestinal diseases or surgeries that affect absorption of drug Congenital galactose intolerance, lactase deficiency and glucosegalactose malabsorption Excessive drinking(exceed 21units/week) Smoking over 10 cigarettes per day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin</keyword>
	<keyword>coadministration</keyword>
</DOC>